186 related articles for article (PubMed ID: 29545182)
1. A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
Ni LH; Tang RN; Lv LL; Wu M; Wang B; Wang FM; Ni HF; Song KY; Wang LT; Meng-Zuo ; Chen Q; Liu BC
Biochem Biophys Res Commun; 2018 Apr; 498(3):654-659. PubMed ID: 29545182
[TBL] [Abstract][Full Text] [Related]
2. Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
Sato H; Goto M; Nishimura G; Morimoto N; Tokushima H; Horii Y; Takahashi N
Bone; 2023 Feb; 167():116613. PubMed ID: 36395959
[TBL] [Abstract][Full Text] [Related]
3. Multiscale effects of the calcimimetic drug, etelcalcetide on bone health of rats with secondary hyperparathyroidism induced by chronic kidney disease.
Sharma S; Kumar S; Tomar MS; Chauhan D; Kulkarni C; Rajput S; Sadhukhan S; Porwal K; Guha R; Shrivastava A; Gayen JR; Kumar N; Chattopadhyay N
Bone; 2024 Aug; 185():117126. PubMed ID: 38777312
[TBL] [Abstract][Full Text] [Related]
4. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
Williams ME
Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
Ota M; Takahata M; Shimizu T; Kanehira Y; Kimura-Suda H; Kameda Y; Hamano H; Hiratsuka S; Sato D; Iwasaki N
Osteoporos Int; 2017 Apr; 28(4):1481-1490. PubMed ID: 27933339
[TBL] [Abstract][Full Text] [Related]
7. Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.
Yu L; Tomlinson JE; Alexander ST; Hensley K; Han CY; Dwyer D; Stolina M; Dean C; Goodman WG; Richards WG; Li X
Calcif Tissue Int; 2017 Dec; 101(6):641-653. PubMed ID: 29038882
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for secondary hyperparathyroidism.
Cozzolino M; Tomlinson J; Walsh L; Bellasi A
Expert Opin Emerg Drugs; 2015 Jun; 20(2):197-208. PubMed ID: 25702624
[TBL] [Abstract][Full Text] [Related]
9. Dentoalveolar Alterations in an Adenine-Induced Chronic Kidney Disease Mouse Model.
Mohamed FF; Amadeu de Oliveira F; Kinoshita Y; Yalamanchili RR; Eltilib LA; Andras NL; Narisawa S; Tani T; Chu EY; Millán JL; Foster BL
J Bone Miner Res; 2023 Aug; 38(8):1192-1207. PubMed ID: 37191192
[TBL] [Abstract][Full Text] [Related]
10. Cortical and trabecular bone are equally affected in rats with renal failure and secondary hyperparathyroidism.
Bajwa NM; Sanchez CP; Lindsey RC; Watt H; Mohan S
BMC Nephrol; 2018 Feb; 19(1):24. PubMed ID: 29394885
[TBL] [Abstract][Full Text] [Related]
11. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
[TBL] [Abstract][Full Text] [Related]
12. Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism.
Sakai M; Tokunaga S; Kawai M; Murai M; Kobayashi M; Kitayama T; Saeki S; Kawata T
PLoS One; 2020; 15(4):e0232428. PubMed ID: 32343734
[TBL] [Abstract][Full Text] [Related]
13. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
Padagas J; Colloton M; Shalhoub V; Kostenuik P; Morony S; Munyakazi L; Guo M; Gianneschi D; Shatzen E; Geng Z; Tan HL; Dunstan C; Lacey D; Martin D
Calcif Tissue Int; 2006 Jan; 78(1):35-44. PubMed ID: 16362459
[TBL] [Abstract][Full Text] [Related]
14. Severe chronic kidney disease environment reduced calcium-sensing receptor expression in parathyroid glands of adenine-induced rats even without high phosphorus diet.
Uchiyama T; Ohkido I; Nakashima A; Saito Y; Okabe M; Yokoo T
BMC Nephrol; 2020 Jun; 21(1):219. PubMed ID: 32517664
[TBL] [Abstract][Full Text] [Related]
15. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
[TBL] [Abstract][Full Text] [Related]
16. Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL/6 mice with more severe deficits in cortical bone properties of male mice.
Metzger CE; Swallow EA; Stacy AJ; Allen MR
PLoS One; 2021; 16(4):e0250438. PubMed ID: 33891630
[TBL] [Abstract][Full Text] [Related]
17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia.
Claramunt D; Gil-Peña H; Fuente R; García-López E; Loredo V; Hernández-Frías O; Ordoñez FA; Rodríguez-Suárez J; Santos F
Am J Physiol Renal Physiol; 2015 Jul; 309(1):F57-62. PubMed ID: 25972508
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet.
Uchiyama T; Tatsumi N; Kamejima S; Waku T; Ohkido I; Yokoyama K; Yokoo T; Okabe M
Hum Cell; 2016 Oct; 29(4):155-61. PubMed ID: 27589858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]